Global Nimesulide Market Size To Worth USD 1516.27 Million By 2033 | CAGR of 5.42%
Category: Food & BeveragesGlobal Nimesulide Market Size To Worth USD 1516.27 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Nimesulide Market Size is Expected to Grow from USD 894.55 Million in 2023 to USD 1516.27 Million By 2033, at a CAGR of 5.42% during the Forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 220 pages with 110 Market data tables and figures & charts from the report on the "Global Nimesulide Market Size, Share, and COVID-19 Impact Analysis, By Formulation (Suspensions, Gels, Tablets, and Others), By Application (Inflammation Treatment, Pain Management, and Others), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, and Others), By End-User (Clinics, Homecare, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/nimesulide-market
The global nimesulide market is a pharmaceutical sector focused on developing, producing, and commercializing non-steroidal anti-inflammatory drugs (NSAIDs) for pain management. Nimesulide, a unique NSAID with a basic sulfonanilide structure, inhibits the enzyme cyclo-oxygenase (COX), blocking the formation of prostaglandins in pain and inflammatory pathways. It is the leading molecule of a new class of sulfonanilides among NSAIDs, showing significant inhibitory selectivity towards cyclooxygenase-2 without affecting cyclooxygenase-1. Nimesulide is used to treat various ailments, including dental work, surgery, sprains, strains, and pain in the ears, nose, and throat. It comes in various forms, such as tablets, syrup, capsules, injectables, oral drops, gel, and solutions. The increasing prevalence of acute pain conditions in the US has accelerated the need for nimesulide medication, leading to market growth. However, the stringent regulatory framework may impede the market growth.
The tablet segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the formulation, the global nimesulide market is categorized as suspensions, gels, tablets, and others. Among these, the tablet segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is driven by patient compliance, stability, cost-effectiveness, ease of administration, longer shelf life, controlled delivery, improved disintegration rate, and rapid action onset.
The pain management segment accounted for a substantial share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the ingredients, the global nimesulide market is categorized as inflammation treatment, pain management, and others. Among these, the pain management segment accounted for a substantial share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment's growth is attributed to the rise in acute and chronic pain conditions, increased awareness of pain management through government and private programs, and improved pain relief methods.
The hospital pharmacies segment held a substantial share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global nimesulide market is categorized as offline and online. Among these, the hospital pharmacies segment held a substantial share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. The sector's growth is fueled by rising chronic pain cases, hospital admissions, inpatient services, advanced healthcare infrastructure, and personalized medication management.
The hospitals segment held the greatest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the end-user, the global nimesulide market is categorized as clinics, homecare, hospitals, and others. Among these, the hospitals segment held the greatest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. The segment growth is driven by the rise in surgical procedures, advanced healthcare infrastructure, and increasing patient admissions to IPD and OPD care services.
Asia Pacific is expected to hold the greatest share of the global nimesulide market over the forecast period.
Get more details on this report -
Asia Pacific is expected to hold the greatest share of the global nimesulide market over the forecast period. Healthcare investments, rising pain and inflammation-related conditions, expanding medication access, aging population, lifestyle disorders, improved infrastructure in China and India, and diverse formulations like tablets, capsules, and gels contribute to the increased availability of nimesulide, catering to diverse patient needs.
North America is predicted to grow at the fastest CAGR throughout the estimated period. The nimesulide market in North America is driven by factors such as the aging population, research and development, chronic pain management, and advanced healthcare infrastructure. The demand for efficient NSAIDs like nimesulide is heightened by chronic pain issues like arthritis and musculoskeletal illnesses. Future expansion may be driven by the reintroduction of nimesulide due to ongoing safety improvements. The aging population's increased prevalence of chronic pain disorders further fuels this market growth.
The Middle East and Africa are projected to hold a substantial share of the global nimesulide market throughout the estimated period. The nimesulide market in the Middle East and Africa is propelled by regional factors like disease prevalence, regulatory frameworks, and healthcare infrastructure. Improved healthcare infrastructure is driving the demand for pain relief medications like nimesulide, especially among older adults.
Major key players in the global nimesulide market are Aurobindo Pharma Ltd., Novartis International AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zydus Cadila, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline plc, Bayer AG, Lupin Limited, Cipla Ltd., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global nimesulide market based on the below-mentioned segments:
Global Nimesulide Market, By Formulation
- Suspensions
- Gels
- Tablets
- Others
Global Nimesulide Market, By Application
- Inflammation Treatment
- Pain Management
- Others
Global Nimesulide Market, By Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Nimesulide Market, By End-User
- Clinics
- Homecare
- Hospitals
- Others
Global Nimesulide Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?